The nuclear magnetic resonance spectrometer market is expanding as pharmaceutical companies, biotechnology firms, academic institutions, chemical manufacturers, and food-testing laboratories require advanced molecular-analysis tools. The market was valued at USD 1.73 billion in 2024 and is projected to reach USD 2.57 billion by 2032, growing at a CAGR of 5.08%.wiseguyreports Nuclear magnetic...